Home Applications 212904 Application 212904
Type NDA
Sponsor AVEO PHARMACEUTICALS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FOTIVDA TIVOZANIB CAPSULE;ORAL 0.89MG Yes No 002 FOTIVDA TIVOZANIB CAPSULE;ORAL 1.34MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212904-001 FOTIVDA TIVOZANIB HYDROCHLORIDE EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 N212904-002 FOTIVDA TIVOZANIB HYDROCHLORIDE EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 N212904-001 12778944 2039-11-05 U-4640 2026-11-10 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 N212904-002 12778944 2039-11-05 U-4640 2026-11-10
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N212904-001 NCE 2026-03-10 N212904-002 NCE 2026-03-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 76 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N212904-001 FOTIVDA EQ 0.89MG BASE CAPSULE / ORAL RLD 2021-03-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N212904-002 FOTIVDA EQ 1.34MG BASE CAPSULE / ORAL RLD, RS 2021-03-10 5d02ea3f76ae…
Observed Orange Book patent history# Patent history page 1 of 5 · 196 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212904-001 12778944 2039-11-05 U-4640 2026-11-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212904-002 12778944 2039-11-05 U-4640 2026-11-10 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 c2088c7a36db…2026-09-14 22:38:34 2026-08 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-001 6821987 2025-04-26 U-3100 Drug substance, Drug product 2021-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-002 6821987 2025-04-26 U-3100 Drug substance, Drug product 2021-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212904-001 6821987 2025-04-26 U-3100 Drug substance, Drug product 2021-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212904-002 6821987 2025-04-26 U-3100 Drug substance, Drug product 2021-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-001 6821987 2025-04-26 U-3100 Drug substance, Drug product 2021-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-001 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-001 11504365 2039-11-05 U-3476 2022-12-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-002 6821987 2025-04-26 U-3100 Drug substance, Drug product 2021-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-002 7166722 2028-11-16 Drug substance, Drug product 2021-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212904-002 11504365 2039-11-05 U-3476 2022-12-01 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 74 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 45629-089 FOTIVDA Tivozanib AVEO Pharmaceuticals, Inc. NDA Current 45629-089 FOTIVDA Tivozanib AVEO Pharmaceuticals, Inc. NDA Current 45629-134 FOTIVDA Tivozanib AVEO Pharmaceuticals, Inc. NDA Current 45629-134 FOTIVDA Tivozanib AVEO Pharmaceuticals, Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 81096 SUPPL 2025-02-06 80969 SUPPL 2025-02-05 79336 SUPPL 2024-08-08 79334 SUPPL 2024-08-08 66993 ORIG 2021-04-06 66912 ORIG 2021-03-29 66745 ORIG 2021-03-11